Verve Therapeutics
About Us
Why Cardiovascular Disease
Our Approach
Our Pipeline
Culture & Careers
Investors
Overview
News & Events
Stock Information
Corporate Governance
Financials & Filings
IR Resources
Verve Therapeutics Corporate Presentation
Post navigation
Previous Post
Previous
Sekar Kathiresan, M.D., Keynote Presentation
Next Post
Next
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Home
About Us
Why Cardiovascular Disease
Our Approach
Our Pipeline
Culture & Careers
Investors
►
◄ Back
Overview
News & Events
Stock Information
Corporate Governance
Financials & Filings
IR Resources
Contact Us